AAAAAA

   
Results: 1-7 |
Results: 7
A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES
Authors: TUMMARELLO D MARI D GRAZIANO F ISIDORI P CETTO G PASINI F SANTO A CELLERINO R
Citation: D. Tummarello et al., A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES, Cancer, 80(12), 1997, pp. 2222-2229
CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY
Authors: TUMMARELLO D GRAZIANO F ISIDORI P SANTO A CETTO G FEDELI A ROSSI G CELLERINO R
Citation: D. Tummarello et al., CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY, Cancer, 77(11), 1996, pp. 2251-2257
SYMPTOMATIC, STAGE-IV, NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESPONSE,TOXICITY, PERFORMANCE STATUS CHANGE AND SYMPTOM RELIEF IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND MITOMYCIN-C
Authors: TUMMARELLO D GRAZIANO F ISIDORI P CELLERINO R
Citation: D. Tummarello et al., SYMPTOMATIC, STAGE-IV, NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESPONSE,TOXICITY, PERFORMANCE STATUS CHANGE AND SYMPTOM RELIEF IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND MITOMYCIN-C, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 249-253
CHEMOTHERAPEUTIC TREATMENT IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - A FURTHER ATTEMPT TO MODULATE CISPLATIN, VINBLASTINE AND MITOMYCIN-C (PVM) SCHEDULE
Authors: TUMMARELLO D ISIDORI P GRAZIANO F MARI D CELLERINO R
Citation: D. Tummarello et al., CHEMOTHERAPEUTIC TREATMENT IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - A FURTHER ATTEMPT TO MODULATE CISPLATIN, VINBLASTINE AND MITOMYCIN-C (PVM) SCHEDULE, Oncology Reports, 1(2), 1994, pp. 415-418
SMALL-CELL LUNG-CANCER (SCLC) - A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE PLUS ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T) AS INDUCTION TREATMENT, FOLLOWED IN COMPLETE RESPONDERS BY ALPHA-INTERFERON OR NO TREATMENT, AS MAINTENANCE THERAPY
Authors: TUMMARELLO D GRAZIANO F MARI D CETTO G PASINI F ANTONIO S ISIDORI P GASPARINI S
Citation: D. Tummarello et al., SMALL-CELL LUNG-CANCER (SCLC) - A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE PLUS ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T) AS INDUCTION TREATMENT, FOLLOWED IN COMPLETE RESPONDERS BY ALPHA-INTERFERON OR NO TREATMENT, AS MAINTENANCE THERAPY, Anticancer research, 14(5B), 1994, pp. 2221-2227
GUIDE TO WRITING FILM SCRIPTS - IMPROVE THE QUALITY OF MEDICAL TEACHING VIDEOTAPES
Authors: ISIDORI P BARRIER JH
Citation: P. Isidori et Jh. Barrier, GUIDE TO WRITING FILM SCRIPTS - IMPROVE THE QUALITY OF MEDICAL TEACHING VIDEOTAPES, Annales de chirurgie, 47(5), 1993, pp. 457-461
A TRIAL OF FAT RICH DIETARY SUPPLEMENTATION IN STABLE COPD PATIENTS WITH SIGNS OF MALNUTRITION
Authors: MARCHESANI F PELA R ISIDORI P ROSSI A CECARINI L SANGUINETTI CM
Citation: F. Marchesani et al., A TRIAL OF FAT RICH DIETARY SUPPLEMENTATION IN STABLE COPD PATIENTS WITH SIGNS OF MALNUTRITION, The American review of respiratory disease, 147(4), 1993, pp. 199-199
Risultati: 1-7 |